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Abstract: Over the last decade, the growing need in disease diagnostics has stimulated 
rapid development of new technologies with unprecedented capabilities. Recent emerging 
infectious diseases and epidemics have revealed the shortcomings of existing diagnostics 
tools, and the necessity for further improvements. Optical biosensors can lay the 
foundations for future generation diagnostics by providing means to detect biomarkers in a 
highly sensitive, specific, quantitative and multiplexed fashion. Here, we review an optical 
sensing technology, Interferometric Reflectance Imaging Sensor (IRIS), and the relevant 
features of this multifunctional platform for quantitative, label-free and dynamic detection. 
We discuss two distinct modalities for IRIS: (i) low-magnification (ensemble biomolecular 
mass measurements) and (ii) high-magnification (digital detection of individual 
nanoparticles) along with their applications, including label-free detection of multiplexed 
protein chips, measurement of single nucleotide polymorphism, quantification of 
transcription factor DNA binding, and high sensitivity digital sensing and characterization 
of nanoparticles and viruses. 
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1. Background and Motivation 
Diagnostics and understanding of the etiology of the disease have been a focus of medical and 
biotechnology research for many years. Disease diagnostics have been evolving through the synergistic 
collaboration of medicine with engineering and science. Until the 20th century, clinical diagnostics 
relied mostly on medical history and physical examination. Clinical tests actually date back thousands 
of years to the time of Hippocrates, when the color and odor of urine was utilized in diagnostics. With 
the advent of the measurement/sensing technologies that provided the ability of detecting trace 
substances in bodily fluids, such as blood, urine, and cerebrospinal fluid, in vitro tests have become a 
cornerstone of clinical practice. These tests range from bacterial cultures to DNA chips for  
genetic profiling and from lateral flow tests to protein microarrays. Despite dramatic technological 
advances over the last decade, recent emerging infectious diseases and epidemics have exposed the 
limitations of current technologies and once again emphasized the importance of continuing innovation 
and refinement. 
Various modalities of biosensing have been applied to detection of biological markers. These 
biomarkers play a critical role both in healthy physiological conditions and during the course of 
diseases that threaten human health, such as cancer, cardiovascular diseases, infectious diseases, 
neurologic diseases, and many others. Depending on the application, diagnostics can rely on detection 
of biomarkers related to infectious agents (such as viruses, bacteria, yeasts, etc.) and toxins, as well as 
markers related to host immune response and changes in the physiological conditions. In recent years, 
the ability to detect biomarkers in extremely low concentrations has led to advances in basic and 
clinical research and in their predictive role regarding diagnosis, prognosis, and progression of 
diseases. Highly sensitive, specific, quantitative, and multiplexed detection of biomarkers will be a 
pivotal focus of the technological evolution of future generation diagnostics [1]. 
A variety of transduction and amplification mechanisms, such as electrochemical, mechanical or 
optical techniques, have been used for detection of serum biomarkers [2,3]. Here we focus on an 
optical biosensor technology that relies on label-free interferometric sensing. Direct monitoring of 
primary molecular binding interactions, without the need for secondary reactants, would markedly 
simplify and expand applications of high-throughput, label-free detection methods. We have developed 
the Interferometric Reflectance Imaging Sensor (IRIS) for label-free, high-throughput, high-sensitivity, 
and dynamic detection of molecular binding on a solid surface, and demonstrated sensing of  
protein-protein binding and DNA-protein binding in a real time, with high sensitivity (~10 pg/mm2) 
and reproducibility [4,5], as well as label-free measurements of DNA hybridization kinetics [6] and 
virus detection [7]. Recent significant advancements in IRIS technology have allowed us to identify 
individual captured nanoparticles based on size and shape [8,9]. This new modality of IRIS is termed 
single-particle IRIS (SP-IRIS) and it allows for high-sensitivity virus detection [10]. In this article, we 
review the operating principles of IRIS and its relevant features for quantitative, label-free, and 
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dynamic detection. We also present the two different modalities for IRIS: (i) low-magnification 
(ensemble biomolecular mass measurements) and (ii) high-magnification (digital detection of 
individual nanoparticles and viruses) along with their applications. 
2. Interferometric Reflectance Imaging Sensor (IRIS) 
The IRIS signal is based upon the interference of the fields reflected off a layered substrate that is 
typically comprised of a SiO2 layer thermally grown atop a Si surface. As previously indicated, IRIS 
renders two distinct detection modalities: (i) high-throughput label-free measurement of biomass 
accumulations; and (ii) digital detection of single particles with high-magnification, also known as 
Single Particle Interferometric Reflectance Imaging Sensor (SP-IRIS). Both modalities are described 
in detail in the following sections. 
2.1. High-Throughput Label-Free Biomass Detection with IRIS 
In this biosensing modality of IRIS, transduction is based on spectral reflectivity. As the overall 
thickness of the upper layer is increased due to biomass accumulation on the surface of the layered 
substrate, the optical path difference (OPD) between top surface of the substrate and the Si-SiO2 
interface also increases, which in turn results in a quantifiable shift in spectral reflectivity (Figure 1). 
The reflectivity curves are sampled at different wavelengths by a CCD and fitted to spectral reflectance 
signatures using Fresnel equations given below: 
ܴ ൌ |ݎ|ଶ ൌ ݎଵ
ଶ ൅ ݎଶଶ ൅ 2ݎଵݎଶ cos 2ϕ
1 ൅ ݎଵଶ ൅ ݎଶଶ ൅ 2ݎଵݎଶ cos 2ϕ 
where ݎଵ ൌ ௡మି௡భ௡మା௡భ, ݎଶ ൌ
௡యି௡మ
௡యା௡మ and ϕ ൌ
ଶ஠ௗ
஛ ݊ଶ cos θ 
where r1 and r2 denote the Fresnel reflection coefficients, n1, n2, and n3 are the indices of refraction for 
air, SiO2, and Si, respectively. λ denotes the wavelength of incident light and θ denotes the angle of 
incidence. As the optical system uses a low-numerical aperture (NA) objective (~0.1, i.e., θ <6°), the 
polarization dependence of the incident light is negligible. 
 
Figure 1. (a) Schematics of the working principle of IRIS showing the interference of light 
reflected from the reference plane (Si-SiO2 interface) with that from the top surface.  
(b) Resulting shift in the wavelength dependent reflectance characteristics due to added 
biomass. A simple optical imaging system (c) using either continuously tunable or discrete 
wavelength sources can be used to determine the surface profile as shown in a typical IRIS 
image of protein spots (d) allowing for measuring molecular binding for thousands of spots. 
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Notice that monitoring the incident light is crucial in order to accurately obtain the reflectivity 
curves from a layered substrate by accounting for any fluctuations in the incident light. Earlier versions 
of IRIS included a photodetector for this purpose, yet a more elegant and simpler technique has been 
implemented in recent versions, where, instead of an additional detector element, a reference region on 
the sensor chip surface has been designated to normalize any fluctuations in the incident light [11]. The 
details of the evolution of the IRIS platform will be provided in the Instrumentation section. 
Low magnification modality of IRIS provides label-free, quantitative, dynamic, and multiplexed 
monitoring of biomolecular binding on the sensor surface. Applications of this modality of IRIS 
include precise quantification of DNA and protein adsorption, real-time monitoring of binding events, 
and accurately measuring the association and disassociation rates. The studies detailed in the Results 
section are critically dependent on these features of the IRIS platform. 
2.2. Digital Detection of Single Particles with SP-IRIS 
Single Particle IRIS (SP-IRIS) has been adapted from the previously described modality of IRIS. 
Essentially, it extends the wide-field interferometric imaging to high spatial resolution using a  
high-NA objective. In this case, the signal is based upon the interference between the scattered field 
from the particle of interest and the reference field reflected off the interface of the layered substrate as 
illustrated in Figure 2 [12]. 
 
Figure 2. (a) In SP-IRIS, visible LED provides illumination, and bright field reflection 
image is captured on a CCD camera; (b) The key to improved visibility of nanoparticles on 
the SP-IRIS system is the mixing of scattered light with reference light reflected from  
the Si-SiO2 interface. The cross term (highlighted) can be orders of magnitude larger than 
the scattered intensity (middle term) for small low-index nanoparticles. Thus when 
illuminated by a narrow spectrum source (LED), surface bound nanoparticles (e.g., viruses) 
become visible; (c) A typical SP-IRIS chip with multiplexed capture antibodies. Detected 
particles appear as diffraction-limited dots in the image and the contrast of the dots can be 
correlated to their sizes, thus allowing for discrimination and elimination of noise in 
complex target solutions. (Reused with permission from [12]). 
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The thickness of the SiO2 layer determines the phase shift introduced between the scattered and 
reflected reference fields, and in SP-IRIS, it is tuned to optimize the signal (contrast) for a given 
particle, enabling highly sensitive detection and counting of nanoscale particles. Furthermore,  
the SP-IRIS signal is primarily affected by the polarizability of the particle (α), amplitude of the 
reference field (Eref) and the phase lag between them (θ) as given in the following equations: 
α ൌ 4π߳௢ݎଷ
߳௣ െ ߳௠
߳௣ ൅ 2߳௠ 
|ܧ௦௖௔|ଶ ∝ αଶ 
ܫ	 ∝ หܧ௥௘௙หଶ ൅ |ܧ௦௖௔|ଶ ൅ 2หܧ௥௘௙ห|ܧ௦௖௔|ܿ݋ݏθ 
In this equation, for small particles, |ܧ௦௖௔|ଶ	can be neglected, and thus the cross term (หܧ௥௘௙ห|ܧ௦௖௔|ሻ 
dominates the signal from the nanoparticles in the SP-IRIS image. In other words, due to interference, 
light reflected from the sensor surface is modified by the presence of particles producing a distinct 
signal that is captured by a camera. This signal appears as a dot in the image and, with a forward 
model, the size of the particle is calculated based on its contrast in the image. In particular, particle 
sizing provides a means to discriminate target particles from impurities such as dust particles and 
aggregates. As the diameters of the particles of interest are much less than the illumination wavelength, 
the forward model assumes the particles to be Rayleigh scatterers, and uses angular spectrum 
representation [13] to obtain the image of the particles in far-field for a wide-field interferometric 
imaging scheme. In this manner, the contrast of the diffraction-limited spot in the image is related to 
the physical size of the particle if the optical properties are known a priori [8,9]. In addition, the signal 
can be tuned by particle geometry, substrate type, illumination wavelength, and defocus. Recent efforts 
to improve SP-IRIS signal included incorporating polarization optics into the system to achieve an 
enhanced signal using metallic particles such as gold nanorods and gold nanospheres. With the aid of 
polarization optics, the reference field can be effectively reduced, extending IRIS platform’s single 
particle detection modality to a partial dark-field interferometric imaging scheme that allows for 
significant contrast enhancements for the nanoparticles. 
The use of functionalized nanoparticles for protein detection promises very high sensitivity along 
with quantitative detection, allowing for single particle/molecule counting. IRIS technology’s 
capability exceeds the state-of-the-art detection systems because it provides single molecule sensitivity 
with non-complex and cost-effective constituents: a simple sensor substrate, LEDs, an optical setup 
with conventional optics, and a CCD detector. 
3. Instrumentation 
IRIS has gone through several stages of commercializable biosensor prototype development since 
its first design in 2007 on an optical bench using a continuously tunable laser source (Figure 3). Within 
a year, a prototype instrument (with a tunable laser) was commercialized by Zoiray Technologies for 
protein microarrays. Starting in 2010, we have replaced the bulky/expensive tunable laser with discrete 
LED sources [14] and reduced the size, cost, complexity, and power requirements of the instrument. 
The evolution of the IRIS and SP-IRIS instrumentation is described in detail in [15]. For the two 
distinct modalities of operation, the significant difference of IRIS instruments is the magnification of 
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the optical system or the numerical aperture of the objective lens. While it is possible to combine both 
modalities in one instrument, utilizing multiple objectives similar to an upright optical microscope 
with a turret, it is often more desirable to optimize other parameters of the overall system for either  
label-free, low-magnification IRIS or the high-magnification SP-IRIS. As shown in Figure 3,  
a low-magnification IRIS system has been reduced in complexity and size after LEDs replaced the 
tunable laser and can be further miniaturized. One of the important performance parameters is the field 
of view (FOV), which can be improved with the advent of camera technology. For example, we have 
demonstrated an IRIS system utilizing a consumer product digital camera with a field of view of 
approximately 1 inch-square. 
 
Figure 3. Early evolution of IRIS: (left) First generation IRIS setup which used a tunable 
laser and spanned half of an optical table; (center) A first generation prototype produced 
by Zoiray Technologies; (right) A second generation IRIS prototype with multi-color  
LED sources. 
Since IRIS allows for accurate and label-free quantitation of the surface bound biomolecules, it can 
be used for quality control of bioassay chips. With a 1 inch-square field of view, biomolecule spots on 
a microarray prepared on an IRIS chip conforming to the size of a microscope slide (25 mm × 75 mm) 
can be read and quantified by taking three images in less than one minute. It is also possible to 
combine label-free calibration with standard fluorescence reading in a single instrument. A hybrid 
prototype that calibrates fluorescence measurements with IRIS mass density measurements has been 
introduced to address the innate problem associated with the variations in probe immobilization that 
can often result in false negatives in immunodiagnostics [16]. The technique is termed calibrated 
florescence enhancement (CaFE) and uses a Si-SiO2 layered sensor chip, which provides tunable 
enhancement in fluorescence emission compared to glass substrates that are usually used in 
fluorescence microarrays [17]. From an optical design standpoint, IRIS and wide-field fluorescence 
imaging have several similarities and two significant differences. Both platforms are top-illuminated, 
also known as reflection-mode, microscopes. For reliable data collection, these instruments require 
uniform and stable illumination of the sample across the FOV. The differences stem from fluorescence 
detection necessitating spectral filters and a high NA collection. Taking into account the requirements 
of the modalities, the hybrid instrument has been designed as shown in Figure 4. 
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Figure 4. CaFE instrument design. (a) Schematic of the optical layout. For fluorescence 
measurements, the second beamsplitter is swapped for a dichroic mirror and an emission 
filter is inserted; (b) Instrument model with main components indicated; (c) Image of the 
actual instrument. (Reused with permission from [16]). 
Due to the high optical magnification, SP-IRIS system requirements are more stringent. For this 
modality, a fully automated prototype allowing for automated focusing and sample scanning, and 
subsequent data analysis has been developed. For this technology to move forward as a diagnostic 
platform, the dependence on the user’s focusing skills must be removed. To this end, an automated and 
easy-to-use SP-IRIS has been designed, constructed, and tested. Two complimentary focusing 
algorithms are implemented in tandem to achieve the ±50 nm accuracy for robust nanoparticle 
detection [14,18]. SP-IRIS technology has been later commercialized by a spin-off from Boston 
University (NexGen Arrays, Inc., Boston, MA, USA). 
4. Applications and Results 
The multifunctional IRIS platform has been extensively utilized in various studies, with results 
described below. As a label-free and quantitative technique, IRIS enables multiplexed protein 
detection. Its dynamic measurement capability allows for single nucleotide polymorphism (SNP) 
determination by DNA melting, and its absolute quantification capability allows for development of 
calibration as well as fundamental studies of transcription factor—DNA binding. Moreover, its digital 
sensing modality (SP-IRIS) allows for high sensitivity virus detection and identification. We review 
examples of these applications below. 
4.1. Label-Free Detection with Protein Microarrays 
IRIS platform’s label-free mass density measurement modality has been a powerful tool for 
applications that require dynamic monitoring of bimolecular interactions to investigate events such as 
disease progression and binding kinetics; and protein microarrays have played a significant role in this 
modality’s development by providing target-specific immunoassays. The utility of this technique has 
been demonstrated in [4], with a particular focus on the dynamic measurements of antibody-antigen 
interactions. The study uses four different protein probes, bovine serum albumin (BSA), human serum 
albumin (HSA), rabbit IgG and protein G, immobilized as multiple spots on an IRIS chip 
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functionalized with an epoxysilane coating. As seen from the results shown in Figure 5, upon reaction 
with a specific antigen, each spot shows a height increase observed over time, allowing for the 
measurements of kinetic association and dissociation rates. A dilution experiment demonstrates a limit 
of detection (LOD) of less than 20 ng/mL corresponding to approximately 120 pM. The LOD for  
the low-magnification, label-free modality of IRIS is calculated from 1.96 times the standard deviation 
divided by the slope of the binding curve in linear region as explained in [4]. 
 
Figure 5. Antibody capture experiment with several layers of interacting antigens and 
antibodies. Upon incubation with anti-HBsAg, anti-HSA, anti-mouse and anti-rabbit 
antibodies, specific capture of these antibodies by the corresponding antigens is observed. 
Bottom panel shows snapshots of representative IRIS images. (Reused with permission 
from [4]). 
Label-free multiplexed virus detection has also been demonstrated on IRIS using serum targets 
containing vesicular stomatitis virus (VSV), as it conveniently offers versatility in terms of 
modification of surface proteins for surrogate detection of hemorrhagic fever viruses (such as Ebola 
and Marburg) whilst maintaining a biosafety level-2 (BSL2) operation [7]. A limit of detection down 
to 3.5 × 105 plaque-forming units/mL (PFU/mL) is confirmed for specific virus detection with a simple 
surface chemistry and minimal sample preparation. 
4.2. Label-Free Detection with DNA Microarrays 
DNA microarrays have gained significant attention in medicine because of their aptitude for 
multiplexed detection of nucleotides and are utilized in a wide variety of applications from gene 
expression profiling to diagnostics. IRIS allows for dynamic label-free quantitation of surface bindings 
and has been deployed for single nucleotide polymorphism (SNP) detection in a DNA microarray 
format in [6]. The study explores the denaturation kinetics and its ionic concentration dependency. 
Dynamic measurements of DNA mass density were carried out over time and DNA denaturation 
kinetics for duplexes with perfect match (PM), single mismatch (SM), and double mismatch (DM), as 
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well as a negative control single stranded DNA probe were observed. The mismatch detection was 
based upon denaturation kinetics measured by the change in the mass density of a spot over time for 
20-basepair PM (20PM), 20MM and 20DM spots. The results (shown in Figure 6) indicate easily 
distinguishable denaturation rates for different types of mismatches. 
 
Figure 6. Kinetic characterization of DNA dissociation. (a) Dynamic dissociation graphs 
of 20 mers; (b) Dynamic dissociation graphs of 18-mers. Single decaying exponentials 
were fit to each of these curves for the time period between 110th and 180th minutes, to 
find the decay constants (shown in the inset plots). (Reused with permission from [6]). 
Moreover, to further quantify the denaturation rates, the measured data was fit to an exponential 
function as shown in Figure 6. The denaturation rates differ significantly, and IRIS is capable of 
detecting SNP with the following confidence intervals obtained from a single spot: 98.6% for 18-mer 
single mismatch detection, 97.2% for 20-mer single mismatch detection, and 88.7% for distinguishing 
18PM from 20PM. The authors also note that those confidence intervals can be improved beyond 99% 
by simply using multiple spots and averaging the data [6]. 
4.3. Protein Detection with DNA Microarrays 
Transcription in eukaryotic cells is initiated by the interactions between a specific type of protein 
called transcription factor (TF) and the promoter region of DNA making up what is known as the 
preinitiation complex (PIC). A deeper understanding of these interactions involving TFs can shed light 
on the eukaryotic transcription initiation processes, hence the resultant gene expression regulations. 
With this goal in mind, IRIS has been used to study those interactions in [19]. Specifically, the study 
explores TATA binding protein (TBP), a key TF that takes part in the initiation of eukaryotic 
transcription. The results indicate high amounts of binding of TBP to both single stranded (ss) and 
double stranded (ds) DNA with a TATA motif, as well as to ss25-mer T. TBP to DNA binding ratio 
for ssDNA and dsDNA with a TATA motif is ~1, whereas this ratio goes up to ~4 for ss25-mer T 
suggesting that multiple TBPs bound to a single ss25-mer T. A computational genome analysis 
revealed that poly-T stretches are abundant (35.5%) in promoter regions. Based on the positional 
analysis of poly-T stretches and TATA box, it is concluded that there are 51 TATA-less promoters that 
can be regulated by TBP through the presence of poly-T stretch in the core promoter. 
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IRIS has also been used to study the ferric uptake regulatory protein (Fur)—a transcriptional 
regulatory protein that functions to control gene transcription in response to iron in a number of 
pathogenic bacteria. Using the high-throughput capability of IRIS, Fur-DNA interactions were 
characterized in vitro with predicted Fur binding sequences in the genome of Neisseria gonorrhoeae, 
the causative agent of the sexually-transmitted disease gonorrhea. These studies demonstrate that 70% 
of the predicted Fur boxes in promoter regions of iron-induced genes bound to Fur, in vitro, with a 
range of affinities as observed using this microarray screening technology. Combining binding data 
with mRNA expression levels in a gonococcal Fur mutant strain allowed for the identification of five 
new gonococcal genes under Fur-mediated direct regulation [20]. 
4.4. Microarray Quality Control and Calibrated Fluorescence Enhancement (CaFE) 
Spot-to-spot and chip-to-chip variability in microarray technology is an essential concern in 
producing reliable data, not only due to technical variations, such as array printing, sample processing, 
analytes, plate, or person, but also due to the inherently varying nature of the capture probes (such as 
proteins) themselves. While fluorescent labeling provides sensitive detection after the assay incubation 
and labeling, it does not allow for determining the amount and the morphology of the capture probe 
spots prior to the experiment. In general, post image processing tools are utilized to improve the 
quality of DNA microarrays, or intermediate labeling steps are utilized for visualization of the printed 
slides prior to incubation [21]. IRIS, with its high-throughput quantification capability, provides an 
excellent platform for microarray quality control if the microarrays are developed on appropriate 
substrates. The basic requirement for the substrate is to have a layered structure (such as an oxide layer 
on Si substrates) to allow for the interferometric signature. It has been shown that Si chips are 
compatible with fluorescence assays and they provide considerable advantages by enhancing the 
fluorescence signal [22], thus allowing for a pre-calibration and quality control by IRIS. In light of 
these advantages, the utility of a calibrated fluorescence enhancement (CaFE) method has been 
demonstrated in [14,15,23] on an integrated platform. Significant improvements have been 
demonstrated for a particular application involving allergen-specific IgE detection with two major 
allergens, peanut (Ara h1) and timothy grass (Phl p1), whose immobilization can vary significantly 
making fluorescence signal calibration vital to obtain accurate results [17]. 
4.5. Single Particle Interferometric Reflectance Imaging Sensor 
SP-IRIS, as a biosensing platform, builds on the established strength and versatility of  
antibody-based assays and adds a simple, but powerful, optical enhancement that allows the direct 
visualization of natural and artificial nano-particles captured on a layered Si chip as described above. 
With this method, particles that were previously too small to be detected by standard microscopy  
(e.g., viruses) can now be directly visualized, counted, and sorted by size and shape for diagnostic 
confidence [8]. Similarly, individual proteins labeled with small metallic nanoparticles can be counted 
on the sensor surface (as conceptually shown in Figure 7) for attomolar-level sensitive detection.  
The sensitivity of the IRIS platform has been dramatically increased with the introduction of single 
particle detection modality enabling digital sensing of nanoscale particles and viruses [24]. Below, we  
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describe results on detection of individual viral pathogens and single protein counting with gold (Au)  
nanoparticle labels. 
 
Figure 7. Concept of the biodetection assay for digital detection and counting of individual 
viral pathogens and antigens decorated with AuNP. (Reused with permission from [12]). 
4.5.1. Digital Label-Free Detection of Viruses 
Application of SP-IRIS for rapid diagnostics have focused on viral hemorrhagic fevers (Ebola, 
Marburg, and Lassa Fever). Detection and identification of virus particles in complex samples for 
replication-competent wild-type vesicular stomatitis virus (VSV), defective VSV, and Ebola- and 
Marburg-pseudotyped VSV have been demonstrated with high sensitivity and specificity in [25]. In 
that study, SP-IRIS chips were incubated with serum or whole blood spiked with virus titrations and 
later washed, dried, and read on the instrument. Size discrimination of the imaged nano-particles 
(virions) facilitates elimination of nonspecifically bound particles to achieve an LOD of 5 × 103 PFU/mL 
(<10 atto-molar of viable virus) for the Ebola and Marburg VSV pseudotypes as shown in Figure 8. 
 
Figure 8. In virus detection experiments, by comparing particles found within the expected 
virus size range for pre- and post-incubation images (a) bound on the specific antibody 
spot, individual virions can be identified and counted. A histogram of virus sizes (b) is 
identified in each image. A size filter is chosen to remove background (noise) particles.  
(c) A typical dilution curve for Ebola VSV pseudotype concentration is shown with an 
LOD of 5 × 103 pfu/mL in serum containing other viruses and bacteria (106 cfu/mL E. coli 
K12 and 105 pfu/mL of Marburg VSV pseudotypes). (Reused with permission from [12]). 
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The LOD for SP-IRIS is calculated from the mean plus three standard deviations of the control 
spots as explained in [25]. Simultaneous detection of multiple viruses in a single sample (serum, 
plasma, or whole blood) for screening applications, as well as uncompromised detection capabilities in 
samples contaminated with high levels of bacteria, have been shown. Both single and dual virus 
samples were made in serum containing 106 CFU/mL E. coli K12. 
4.5.2. Multiplexed Protein Detection with Au Nanoparticle Labels 
Since individual proteins are too small to be identified as particles, SP-IRIS utilizes nanoparticles as 
labels for “digital” detection. Such an approach is commonly referred to as “mass-tagging” and is a 
widely used method to enhance sensitivity. However, typical mass tagging requires micron-size 
particles resulting in limitations due to diffusion and steric hindrance caused by the large particle [26,27]. 
In contrast, SP-IRIS can detect Au nanoparticles as small as 20 nm, which is only about twice the 
hydrodynamic diameter of an antibody. 
Using this approach, detection of a protein biomarker, β-lactoglobulin, in both unprocessed serum 
and human whole blood has been demonstrated in [28]. Figure 9 shows the concept and a dilution 
curve for β-lactoglobulin incubated for 2 h in serum and in whole blood with a detection limit of  
60 aM and 500 aM, respectively. Direct detection of protein biomarkers with attomolar sensitivity 
without the need of sample preparation can pave the way for performing diagnostic tests at the point of 
care. Furthermore, quantitation of allergen-specific IgE from unprocessed finger prick volume of 
human blood has also been shown in [28]. 
 
Figure 9. (a) Conceptual representation of SP-IRIS single molecule counting assay for 
protein biomarker detection; (b) Representative images at 1 pg/mL and 100 pg/mL target 
concentration; (c) Dilution curve for β-lactoglobulin in unprocessed serum and whole 
blood shown in blue and red, respectively. (Reused with permission from [28]). 
5. Alternative Techniques and Performance Comparisons 
The development of label-free detection methods have enabled the study of primary interactions 
between biomolecules, such as antigen-antibody and protein-DNA, without requiring secondary probes 
binding to target analytes for a quantifiable signal [4]. ELISA, one of the most widely used 
immunoassays, is a label-based technique that makes use of the enzyme-linked secondary reagents to 
obtain a quantifiable signal [14]. The main disadvantage of this type of secondary probe-based 
1 pg/mL 
100 pg/mL 
BSA An -B-lactoglobulin 
(a) (b) (c) 
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biosensors is the complexity of the immunoassay due to its need for multiple binding layers. A critical 
innovative aspect of the IRIS platform is its ability to detect both biomasses and nanoscale particles in 
a label-free manner with its two distinct modalities. 
As discussed earlier, SP-IRIS enables the label-free detection of individual virions captured onto the 
sensor surface overcoming a host of unique challenges due to their small size, low refractive index and 
polydispersity. Surface plasmon resonance (SPR) has been the leading technology among label-free 
detection methods [29], but for single particle detection, it has shown limited success partially due to 
the inherent roughness of the Au surface utilized in SPR. Other label-free optical biodetection 
technologies have generated interest with their simple and high-throughput operation as well; in 
particular, BIND (biomolecular interaction detector), utilizing diffraction gratings, has been applied to 
single particle detection [30]. In addition, resonant optical cavities, such as whispering gallery mode 
(WGM) sensors, as explained in [31], have also shown single particle detection capability. However, 
these frequency-shift-based sensors lack robust particle detection capacity, as their signal is highly 
dependent upon the binding position of the nanoparticle with regards to the evanescent tail of the 
optical wave on the resonator [9]. Thus, the aforementioned complex and delicate optical sensor 
systems have yet to show the robust single particle detection and analysis capability with size 
discrimination in complex biological fluids. 
Akin to SP-IRIS, other interferometric nanoparticle detection methods have also been developed 
over the years. These include a method implementing confocal microscopy in an interferometric scheme 
using supercontinuum laser illumination [32], interferometric detection of scattering (iSCAT) [33],  
and another method implementing a background-free, interferometric scattering measurement of 
nanoparticles using a split detector [34]. All of the aforementioned interferometric techniques use a 
laser as a light source, which, owing to its highly coherent nature, results in speckles in the images, 
requiring further optical tools to overcome, as the speckles contribute to reduced signal-to-noise ratio. 
Furthermore, [32] requires sample scanning in a complex confocal setup, making it a costly alternative 
with no multiplexed detection capability, and [33] employs laser beam scanning using acusto-optic 
deflectors, which makes the detection platform expensive and very limited in terms of high-throughput. 
Table 1. Performance comparisons for the IRIS platform and its alternatives in terms of the 
limit of detection. 
Biosensor Analyte Limit of Detection Reference
SP-IRIS 
Protein (β-lactoglobulin) 60 aM [28] 
Virus (Ebola-pseudotyped VSV) 5 × 103 pfu/mL (<10 aM) [25] 
IRIS * 
Protein (rabbit-IgG) 19 ng/mL (~120 pM) [4] 
Protein (BSA) 5.2 pg/mm2 [14] 
Virus (VSV) 3.5 × 105 pfu/mL [7] 
iSCAT Protein (IgG1) 1 ng/mL (~6 pM) [35] 
WGM 
Protein 0.03 pg/mm2 [31] 
Virus (InfA) 10 fM [36] 
SPRi 
Protein (β2m/cysC) 1 nM [37] 
DNA 10 nM [38] 
* The low-magnification biomass detection modality of the IRIS platform is referred to as SRIB (Spectra 
Reflectance Imaging Biosensor) in [4]. 
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In Table 1, we provide a performance summary in terms of the limit of detection of the IRIS 
platform and other widely used alternative techniques as previously mentioned. 
As can be seen from Table 1, the label-free biomass detection and digital single particle detection 
modalities together make the IRIS a biosensing platform with an unprecedentedly wide dynamic range 
in comparison with its alternatives [28]. 
6. Conclusions 
For clinical applications, there is a need for diagnostics tools with sensitivity compared to existing 
state-of-the-art technologies without complicated assays, sample preparation, and bulky equipment. 
With the IRIS platform reviewed here, we have demonstrated detection of diagnostics targets of 
clinically relevant units from complex samples, with sensitivities comparable to laboratory assays, but 
in a much simpler format. IRIS offers detection of a variety of targets such as proteins, nucleic acids, 
and whole viruses in a simple assay format and with high sensitivity (at single pathogen or molecule 
resolution). In addition, its compact design, robustness, and low cost make the platform a promising 
tool for point-of-care assays. Through integration with microfluidics, IRIS may be implemented for 
critical point-of-care applications such as detection of biomarkers from unprocessed blood in primary 
care setting for early diagnosis or sample-to-answer virus detection in resource-poor rural settings for 
infectious disease control and containment during an outbreak. 
Acknowledgments 
A number of people have contributed to the body of work reviewed in this article. We are 
particularly indebted to Marcella Chiari and Marina Cretich of CNR, Milan, and John Connor,  
Bennett Goldberg, Emre Ozkumur, Sunmin Ahn, George Daaboul, Margo Monroe, Alex Reddington, 
Carlos Lopez, Abdulkadir Yurt, and Rahul Vedula of Boston University, as well as other current and 
past members of the Ünlü lab at Boston University. Funding support for the interferometric reflectance 
imaging sensor (IRIS) research has been provided by a variety of sources including National Institutes 
of Health (R21 GM074872-01A1, R21EB015900, R01AI1096159) Army Research Laboratory 
(W911NF-06-2-0040), National Science Foundation (OISE-0601631, EEC-0812056, AIR-1127833), 
MITRE Corporation, Center for Integration of Medicine and Innovative Technology (CIMIT). O. Avci 
acknowledges support from Bahcesehir University—Boston University fellowship. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. Gubala, V.; Harris, L.F.; Ricco, A.J.; Tan, M.X.; Williams, D.E. Point of care diagnostics: Status 
and future. Anal. Chem. 2012, 84, 487–515. 
2. Li, R.; Wu, D.; Li, H.; Xu, C.; Wang, H.; Zhao, Y.; Cai, Y.; Wei, Q.; Du, B. Label-free 
amperometric immunosensor for the detection of human serum chorionic gonadotropin based on 
nanoporous gold and grapheme. Anal. Biochem. 2011, 414, 196–201. 
Sensors 2015, 15 17663 
 
 
3. Stoeva, S.I.; Lee, J.S.; Smith, J.E.; Rosen, S.T.; Mirkin, C.A. Multiplexed detection of protein 
cancer markers with biobarcoded nanoparticle probes.  J. Am. Chem. Soc. 2006, 128, 8378–8379. 
4. Özkumur, E.; Needham, J.W.; Bergstein, D.A.; Gonzalez, R.; Cabodi, M.; Gershoni, J.M.; 
Goldberg, B.B.; Ünlü, M.S. Label-free and dynamic detection of biomolecular interactions for 
high-throughput microarray applications. Proc. Natl. Acad. Sci. USA 2008, 105, 7988–7992. 
5. Özkumur, E.; Yalçın, A.; Cretich, M.; Lopez, C.A.; Bergstein, D.A.; Goldberg, B.B.; Chiari, M.; 
Ünlü, M.S. Quantification of DNA and protein adsorption by optical phase shift. Biosens. Bioelectron. 
2009, 25, 167–172. 
6. Özkumur, E.; Ahn, S.; Yalçın, A.; Lopez, C.A.; Çevik, E.; Irani, R.J.; DeLisi, C.; Chiari, M.; 
Ünlü, M.S. Label-free microarray imaging for direct detection of DNA hybridization and  
single-nucleotide mismatches. Biosens. Bioelectron. 2010, 25, 1789–1795. 
7. Lopez, C.A.; Daaboul, G.G.; Vedula, R.S.; Özkumur, E.; Bergstein, D.A.; Geisbert, T.W.; 
Fawcett, H.E.; Goldberg, B.B.; Connor, J.H.; Ünlü, M.S. Label-free, multiplexed virus detection 
using spectral reflectance imaging. Biosens. Bioelectron. 2011, 26, 3432–3437. 
8. Daaboul, G.G.; Yurt, A.; Zhang, X.; Hwang, G.M.; Goldberg, B.B.; Ünlü, M.S. High-throughput 
detection and sizing of individual low-index nanoparticles and viruses for pathogen identification. 
Nano Lett. 2010, 10, 4727–4731. 
9. Yurt, A.; Daaboul, G.G.; Connor, J.H.; Goldberg, B.B.; Ünlü, M.S. Single nanoparticle detectors 
for biological applications. Nanoscale 2012, 4, 715–726. 
10. Daaboul, G.G.; Lopez, C.A.; Yurt, A.; Member, S.; Goldberg, B.B. Label-free optical biosensors 
for virus detection and characterization. Sel. Top. Quantum Electron. IEEE J. 2012, 18, 1422–1433. 
11. Vedula, R.; Daaboul, G.; Reddington, A.; Özkumur, E.; Bergstein, D.A.; Ünlü, M.S. Self-referencing 
substrates for optical interferometric biosensors. J. Mod. Opt. 2010, 57, 1564–1569. 
12. Ünlü, M.S. Digital detection of nanoparticles: Viral diagnostics and multiplexed protein and 
nucleic acid assays. MRS Proc. 2014, doi:10.1557/opl.2015.4. 
13. Novotny, L.; Hecht, B. Principles of Nano-Optics, 2nd ed.; Cambridge University Press: 
Cambridge, UK, 2012. 
14. Daaboul, G.G.; Vedula, R.S.; Ahn, S.; Lopez, C.A.; Reddington, A.; Ozkumur, E.; Ünlü, M.S. 
LED-based interferometric reflectance imaging sensor for quantitative dynamic monitoring of 
biomolecular interactions. Biosens. Bioelectron. 2011, 26, 2221–2227. 
15. Reddington A.P. Instrument Design and Optimization of Interferometric Reflectance Imaging 
Sensors for in Vitro Diagnostics. Ph.D. Thesis, Boston University, Boston, MA, USA, January 2014. 
16. Reddington, A.P.; Monroe, M.R.; Ünlü, M.S. Integrated imaging instrument for self-calibrated 
fluorescence protein microarrays. Rev. Sci. Instrum. 2013, 84, 103702. 
17. Monroe, M.R.; Reddington, A.P.; Collins, A.D.; LaBoda, C.; Cretich, M.; Chiari, M.; Little, F.F.; 
Ünlü, M.S. Multiplexed method to calibrate and quantitate fluorescence signal for allergen-specific 
IgE. Anal. Chem. 2011, 83, 9485–9491. 
18. Reddington, A.P.; Member, S.; Trueb, J.T.; Freedman, D.S.; Tuysuzoglu, A.; Member, S.; 
Daaboul, G.G.; Lopez, C.A.; Karl, W.C.; Member, S.; et al. An Interferometric Reflectance 
Imaging Sensor for Point of Care Viral Diagnostics. IEEE Trans. Biomed. Eng. 2013, 60,  
3276–3283. 
Sensors 2015, 15 17664 
 
 
19. Ahn, S.; Huang, C.-L.; Ozkumur, E.; Zhang, X.; Chinnala, J.; Yalcin, A.; Bandyopadhyay, S.; 
Russek, S.; Ünlü, M.S.; DeLisi, C.; et al. TATA binding proteins can recognize nontraditional 
DNA sequences. Biophys. J. 2012, 103, 1510–1517. 
20. Yu, C.; Lopez, C.A.; Hu, H.; Xia, Y.; Freedman, D.S.; Reddington, A.P.; Daaboul, G.G.; Ünlü, M.S.; 
Genco, C.A. A high-throughput method to examine protein-nucleotide interactions identifies 
targets of the bacterial transcriptional regulatory protein Fur. PLoS ONE 2014, 9, e96832. 
21. Hessner, M.; Singh, V.; Wang, X.; Khan, S.; Tschannen, M.; Zahrt, T. Utilization of a labeled 
tracking oligonucleotide for visualization and quality control of spotted 70-mer arrays.  
BMC Genomics 2004, 5, 12. 
22. Francesca, B.; Francesco, D.; Vincenza, C.; Silvia, G.; Gabriele, D.C.; Manuela, S.; Luigi, P.; 
Maurizio, F.; Marcella, C.; Laura, C. High-sensitive microarray substrates specifically designed to 
improve sensitivity for the identification of fetal paternally inherited sequences in maternal 
plasma. Clin. Chem. Lab. Med. 2009, 47, 818–823. 
23. Cretich, M.; Monroe, M.R.; Reddington, A.; Zhang, X.; Daaboul, G.G.; Damin, F.; Sola, L.;  
Unlu, M.S.; Chiari, M. Interferometric silicon biochips for label and label-free DNA and protein 
microarrays. Proteomics 2012, 12, 2963–2977. 
24. Sevenler, D.; Ünlü, N.L.; Ünlü, M.S. Nanoparticle biosensing with interferometric reflectance 
imaging. In Nanobiosensors and Nanobioanalyses; Vestergaard, M.C., Kerman, K., Hsing, I.M., 
Tamiya, E., Eds.; Springer: Tokyo, Japan, 2015. 
25. Daaboul, G.G.; Lopez, C.A.; Chinnala, J.; Goldberg, B.B.; Connor, J.H.; Ünlü, M.S. Digital 
sensing and sizing of vesicular stomatitis virus pseudotypes in complex media: A model for ebola 
and marburg detection. ACS Nano 2014, 8, 6047–6055. 
26. Luchansky, M.S.; Washburn, A.L.; McClellan, M.S.; Bailey, R.C. Sensitive on-chip detection of a 
protein biomarker in human serum and plasma over an extended dynamic range using silicon photonic 
microring resonators and sub-micron beads. Lab Chip 2011, 11, 2042–2044. 
27. Sheehan, P.E.; Whitman, L.J. Detection limits for nanoscale biosensors. Nano Lett. 2005, 5,  
803–807. 
28. Monroe, M.R.; Daaboul, G.G.; Tuysuzoglu, A.; Lopez, C.A.; Little, F.F.; Ünlü, M.S. Single 
nanoparticle detection for multiplexed protein diagnostics with attomolar sensitivity in serum and 
unprocessed whole blood. Anal. Chem. 2013, 85, 3698–3706. 
29. Steiner, G. Surface plasmon resonance imaging. Anal. Bioanal. Chem. 2004, 379, 328–331. 
30. Zhuo, Y.; Hu, H.; Chen, W.; Lu, M.; Tian, L.; Yu, H.; Long, K.D.; Chow, E.; King, W.P.; 
Singamaneni, S.; et al. Single nanoparticle detection using photonic crystal enhanced microscopy. 
Analyst 2014, 139, 1007–1015. 
31. Vollmer, F.; Arnold, S. Whispering-gallery-mode biosensing: Label-free detection down to single 
molecules. Nat. Meth. 2008, 5, 591–596. 
32. Lindfors, K.; Kalkbrenner, T.; Stoller, P.; Sandoghdar, V. Detection and spectroscopy of gold 
nanoparticles using supercontinuum white light confocal microscopy. Phys. Rev. Lett. 2004,  
93, 037401. 
33. Ortega-Arroyo, J.; Kukura, P. Interferometric scattering microscopy (iSCAT): New frontiers in 
ultrafast and ultrasensitive optical microscopy. Phys. Chem. Chem. Phys. 2012, 14, 15625. 
Sensors 2015, 15 17665 
 
 
34. Ignatovich, F.V.; Novotny, L. Real-time and background-free detection of nanoscale particles. 
Phys. Rev. Lett. 2006, 96, 013901. 
35. Piliarik, M.; Sandoghdar, V. Direct optical sensing of single unlabelled proteins and super-resolution 
imaging of their binding sites. Nat. Commun. 2014, 5, doi:10.1038/ncomms5495 
36. Vollmer, F.; Arnold, S.; Keng, D. Single virus detection from the reactive shift of a  
whispering-gallery mode. Proc. Natl. Acad. Sci. USA 2008, 105, 20701–20704. 
37. Lee, H.J.; Nedelkov, D.; Corn, R.M. Surface plasmon resonance imaging measurements of 
antibody arrays for the multiplexed detection of low molecular weight protein biomarkers.  
Anal. Chem. 2006, 78, 6504–6510. 
38. Nelson, B.P.; Grimsrud, T.E.; Liles, M.R.; Goodman, R.M.; Corn, R.M. Surface plasmon 
resonance imaging measurements of DNA and RNA hybridization adsorption onto DNA 
microarrays. Anal. Chem. 2001, 73, 1–7. 
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
